Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary for 3.4.24.B9 extracted from

  • Baggen, J.; Jan Thibaut, H.; Hurdiss, D.; Wahedi, M.; Van Vliet, A.; Van Kuppeveld, F.
    Identification of the cell-surface protease adam9 as an entry factor for encephalomyocarditis virus (2019), mBio, 10, e1780 .
    View publication on PubMedView publication on EuropePMC

Application

Application Comment Organism
medicine cells lacking ADAM9 show a significant reduction in infection efficiency by encephalomyocarditis virus EMCV. Pharmacological inhibition of the metalloproteinase activity of ADAM9 does not affect virus infection. Reconstitution of inactive ADAM9 in knockout cells restores susceptibility to EMCV. ADAM9 facilitates attachment of EMCV to the cell surface Homo sapiens

Localization

Localization Comment Organism GeneOntology No. Textmining
cell surface
-
Homo sapiens 9986
-

Organism

Organism UniProt Comment Textmining
Homo sapiens Q13443
-
-

Source Tissue

Source Tissue Comment Organism Textmining
HAP-1 cell
-
Homo sapiens
-

General Information

General Information Comment Organism
physiological function cells lacking ADAM9 show a significant reduction in infection efficiency by encephalomyocarditis virus EMCV. Pharmacological inhibition of the metalloproteinase activity of ADAM9 does not affect virus infection. Reconstitution of inactive ADAM9 in knockout cells restores susceptibility to EMCV. ADAM9 facilitates attachment of EMCV to the cell surface Homo sapiens